Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial



Durez, Patrick, Pavelka, Karel, Alicia Lazaro, Maria, Garcia-Kutzbach, Abraham, Moots, Robert J ORCID: 0000-0001-7019-6211, Amital, Howard, Govoni, Marinella and Vastesaeger, Nathan
(2018) Regional differences in baseline disease activity and remission rates following golimumab treatment for RA: results from the GO-MORE trial. CLINICAL RHEUMATOLOGY, 37 (5). 1417 - 1420.

[img] Text
GO-MORE regional article_draft 2.docx - Accepted Version

Download (80kB)
Item Type: Article
Uncontrolled Keywords: Antirheumatic agents, Clinical trial, Geographic locations, Golimumab, Rheumatoid arthritis
Depositing User: Symplectic Admin
Date Deposited: 14 Nov 2018 10:21
Last Modified: 02 Apr 2021 18:11
DOI: 10.1007/s10067-018-4074-6
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3021464